| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $610.8M | -1.3% |
| Cost of Revenue | $196.3M | -6.3% |
| Gross Profit | $414.5M | +1.3% |
| R&D Expense | $264.7M | -2.1% |
| SG&A Expense | $344.3M | +0.3% |
| Operating Income | -$194.6M | +26.7% |
| Pre-tax Income | -$177.7M | +28.6% |
| Income Tax | $4.9M | -22.2% |
| Net Income | -$182.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $344.1M | -4.2% |
| Accounts Receivable | $87.9M | -23.5% |
| Inventory | $83.1M | +12.8% |
| Current Assets | $584.4M | -2.0% |
| Total Assets | $918.6M | -4.8% |
| Current Liabilities | $117.6M | -7.5% |
| Total Liabilities | $208.5M | -7.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.7M | +143.9% |
| Capital Expenditures | $12.4M | -74.5% |
| Investing Cash Flow | -$32.6M | -124.4% |
| Financing Cash Flow | $10.9M | -20.2% |
| Free Cash Flow | -$5.7M | +91.0% |
| +28.4% |
| EPS (Basic) | -$1.52 | +30.3% |
| EPS (Diluted) | -$1.52 | +30.3% |
| Stockholders' Equity |
| $710.1M |
| -4.2% |